Inhibrx, Inc. Quarterly Operating Margin in % from Q4 2020 to Q1 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Inhibrx, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q1 2024.
  • Inhibrx, Inc. Operating Margin for the quarter ending March 31, 2024 was -14K %, a 24.4% decline year-over-year.
  • Inhibrx, Inc. annual Operating Margin for 2023 was -12.2K %, a 107% decline from 2022.
  • Inhibrx, Inc. annual Operating Margin for 2022 was -5.89K %, a 456% decline from 2021.
  • Inhibrx, Inc. annual Operating Margin for 2021 was -1.06K %, a 102% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -14K -2.74K -24.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -12.2K -6.29K -107% Oct 1, 2023 Dec 31, 2023
Q3 2023 -37.8K -35.5K -1498% Jul 1, 2023 Sep 30, 2023
Q2 2023 -25.1K -23.7K -1635% Apr 1, 2023 Jun 30, 2023
Q1 2023 -11.2K -10K -839% Jan 1, 2023 Mar 31, 2023
Q4 2022 -5.89K -4.83K -456% Oct 1, 2022 Dec 31, 2022
Q3 2022 -2.37K -1.33K -128% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.45K -774 -115% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.2K -667 -126% Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.06K -536 -102% Oct 1, 2021 Dec 31, 2021
Q3 2021 -1.04K Jul 1, 2021 Sep 30, 2021
Q2 2021 -675 Apr 1, 2021 Jun 30, 2021
Q1 2021 -530 Jan 1, 2021 Mar 31, 2021
Q4 2020 -523 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.